Molecular determinants of invasion in endometrial cancer

被引:0
|
作者
M. Abal
M. Llauradó
A. Dolla
M. Monge
E. Colas
M. González
M. Rigau
H. Alazzouzi
S. Demajo
J. Castellví
A. García
S. Ramón y Cajal
J. Xercavins
M. H. Vázquez-Levin
F. Alameda
A. Gil-Moreno
J. Reventos
机构
[1] Research Institute Vall d’Hebron University Hospital,Biomedical Research Unit
[2] Vall d’Hebron University Hospital,Pathology Department
[3] Vall d’Hebron University Hospital,Gynecological Oncology Department
[4] Instituto de Biología y Medicina Experimental CONICET,Pathology Department
[5] Hospital del Mar,undefined
[6] Autonomous University of Barcelona,undefined
来源
Clinical and Translational Oncology | 2007年 / 9卷
关键词
Endometrial cancer; Myometrial infiltration; Metastasis; Epithelial to mesenchymal transition; E-cadherin; ETV5; RUNX1;
D O I
暂无
中图分类号
学科分类号
摘要
Endometrial carcinoma is the most common gynaecological malignancy in the western world and the most frequent among infiltrating tumours of the female genital tract. Despite the characterisation of molecular events associated with the development of endometrial carcinoma, those associated with the early steps of infiltration and invasion in endometrial cancer are less known. Deep myometrial invasion correlates with more undifferentiated tumours, lymph-vascular invasion, node affectation and decreased global survival. In this review we present an overview of the molecular pathology of myometrial infiltration that defines the initial steps of invasion in endometrial cancer. Down-regulation of E-cadherin as a main player of epithelial to mesenchymal transition, as well as modifications on other molecules involved in cell-cell contacts, render cells with a migratory phenotype. In addition, altered signalling pathways and transcription factors associate with myometrial invasion, histologic grade and metastasis.
引用
收藏
页码:272 / 277
页数:5
相关论文
共 50 条
  • [21] Molecular genetics and endometrial cancer
    Lalloo, F
    Evans, G
    BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY, 2001, 15 (03): : 355 - 363
  • [22] Molecular Pathology of Endometrial Cancer
    Arends, M. J.
    JOURNAL OF PATHOLOGY, 2016, 240 : 3 - 3
  • [23] Molecular classification of endometrial cancer
    Ince, TA
    Baker, HE
    Kust, GA
    Mutter, GL
    LABORATORY INVESTIGATION, 2003, 83 (01) : 193A - 193A
  • [24] Molecular classification of endometrial cancer
    Bronsert, Peter
    Kurowski, Konrad
    Werner, Martin
    Unger, Clara
    Timme, Sylvia
    GYNAKOLOGIE, 2023, 56 (03): : 164 - 175
  • [25] Molecular factors in endometrial cancer
    Markowska, A.
    Bocianowska, M.
    Markowska, J.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (02) : 190 - 192
  • [26] Molecular classification of endometrial cancer
    Ince, TA
    Baker, HE
    Kust, GA
    Mutter, GL
    MODERN PATHOLOGY, 2003, 16 (01) : 193A - 193A
  • [27] Molecular markers and endometrial cancer
    D'Oria, Ottavia
    Bogani, Giorgio
    Vizza, Enrico
    Chiantera, Vito
    Muzii, Ludovico
    Salerno, Maria Giovanna
    Caserta, Donatella
    Lagana, Antonio Simone
    Tinelli, Andrea
    Corrado, Giacomo
    Giannini, Andrea
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2022, 43 (06) : 1 - 3
  • [28] Pan-cancer Transcriptomic Determinants Of Perineural Invasion And Lymphovascular Invasion
    Guo, J. A.
    Hoffman, H. I.
    Hwang, P. G.
    Kim, D. Y.
    Alshalalfa, M.
    Mahal, B. A.
    Hong, T. S.
    Hwang, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E511 - E511
  • [29] Molecular determinants of human uveal melanoma invasion and metastasis
    Seftor, EA
    Meltzer, PS
    Kirschmann, DA
    Pe'er, J
    Maniotis, AJ
    Trent, JM
    Folberg, R
    Hendrix, MJC
    CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (03) : 233 - 246
  • [30] Molecular determinants of human uveal melanoma invasion and metastasis
    Elisabeth A. Seftor
    Paul S. Meltzer
    Dawn A. Kirschmann
    Jacob Pe'er
    Andrew J. Maniotis
    Jeffrey M. Trent
    Robert Folberg
    Mary J.C. Hendrix
    Clinical & Experimental Metastasis, 2002, 19 : 233 - 246